ATLANTA, March 27,
2023 /PRNewswire/ -- The Craneware Group (AIM:
CRW.L), the healthcare market leader in automated value cycle
solutions, today publicly announces it supports and underwrites the
advocacy group 340B Matters.
340B
Matters is an informational campaign that seeks to protect the
340B program for the nonprofit
healthcare facilities and patients who benefit from it.
In 2016, guided by a concern for the future of the 340B program, Sentry Data Systems, now The
Craneware Group, launched 340B
Matters. The core mission of the advocacy group is to protect the
vital drug discount program from corporate entities aiming to
severely restrict access to reduced cost outpatient medications for
nonprofit healthcare organizations. Known for candidly and without
reservation tackling drug manufacturers that lobby for their own
profits, 340B Matters also shines a
light on pharma's tendencies to AstroTurf struggling healthcare
organizations, spreading false narratives and pitting safety-net
providers against each other in a near-constant attempt to degrade
the benefits of the 340B program.
Under the slogan, we support patients over profits, the
advocacy group lends a voice to all safety-net hospitals that
provide accessible and affordable care to their most vulnerable
populations.
"The Craneware Group, in stepping forward as the power behind
340BMatters, is demonstrating our continued and unwavering
commitment to being more than just a revenue intelligence and
340B performance partner. We are
committed to transforming the business of healthcare with our
customers, closely engaging with them to achieve operational and
financial goals that make healthcare more accessible and affordable
for more people; including advocacy efforts to support safety-net
providers and their mission to serve the unmet need in their
communities." - Keith Neilson,
CEO
At this year's 340B Coalition
Winter Conference, The Craneware Group's Senior Vice President of
Industry Relations and author of the award-winning 340Buzz,
Lisa M. Scholz, PharmD, MBA, FACHE,
will present on opportunities to strengthen 340B performance and compliance. Conference
attendees can visit booth number 409 to learn more about
340B Matters and sign up for the
340B Matters newsletter. They can
also stay abreast of the latest developments by following
340B Matters on Twitter, LinkedIn,
and Facebook.
About The Craneware Group
The Craneware Group (AIM:CRW.L), the market leader in automated
value cycle solutions, including 340B
management, collaborates with U.S. healthcare providers to plan,
execute, and monitor operational and financial performance so they
can continue to deliver quality care to their communities.
Customers choose The Craneware Group's Trisus data and applications
platform as their key to navigating the journey to financially
sustainable value-based care. Trisus combines revenue integrity,
cost management, 340B performance,
and decision enablement into a single, SaaS-based platform. Trisus
Chargemaster secured top ranking in the Chargemaster Management
category of the "2023 Best in KLAS Awards: Software & Services"
and is part of an extensive value cycle management suite. The
Craneware Group – transforming the business of healthcare. Learn
more at www.thecranewaregroup.com.
About 340BMatters
340B Matters is an informational campaign that seeks to protect the
340B program for the nonprofit
healthcare facilities and patients who benefit from it.
340B Matters is supported and
underwritten by Sentry Data Systems, now The Craneware Group.
The Craneware Group Media Contact:
Mark Montgomery
Chief Marketing Officer
m.montgomery@craneware.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/the-craneware-group-announces-it-supports-and-underwrites-advocacy-group-340b-matters-301781484.html
SOURCE Craneware